Compositions for making and using anti-Myostatin antibodies Grant US-11925683-B2 United States of America 12 Mar 2024
Activin receptor type IIB variants and methods of use thereof Grant US-11884715-B2 United States of America 30 Jan 2024
Nucleic acid molecules encoding activin receptor type IIA variants Grant US-11717558-B2 United States of America 08 Aug 2023
Activin receptor type IIa variants and methods of use thereof Grant US-11484573-B2 United States of America 01 Nov 2022
Methods for using anti-myostatin antibodies Grant US-11439704-B2 United States of America 13 Sep 2022
Compositions and methods for making and using anti-myostatin antibodies Grant US-11155611-B2 United States of America 26 Oct 2021
Methods for making and using anti-myostatin antibodies Grant US-11135291-B2 United States of America 05 Oct 2021
Activin receptor type IIa variants and methods of use thereof Grant US-11090361-B2 United States of America 17 Aug 2021
Activin receptor type IIA variants and methods of use thereof Grant US-11013785-B2 United States of America 25 May 2021
Use of myostatin inhibitors and combination therapies Grant US-10946036-B2 United States of America 16 Mar 2021
Methods for inhibiting myostatin activation by administering anti-pro/latent myostatin… Grant US-10882904-B2 United States of America 05 Jan 2021
Anti-pro/latent-Myostatin antibodies and uses thereof Grant US-10751413-B2 United States of America 25 Aug 2020
Methods for inhibiting myostatin activation by administering anti-pro/latent myostatin… Application US-10287345-B2 United States of America 14 May 2019
Method for treating muscle wasting syndrome using antagonist antibodies against GDF-8 Grant US-9926368-B2 United States of America 27 Mar 2018
Antagonist antibodies against GDF-8 and uses therefor Grant US-9751937-B2 United States of America 05 Sep 2017
ANTI-PRO/LATENT MYOSTATIN ANTIBODIES AND METHODS OF USE THEREOF Application WO-2017120523-A3 World Intellectual Property Organisation (WIPO) 17 Aug 2017
Antagonist antibodies against GDF-8 and uses therefor Grant US-8992913-B2 United States of America 31 Mar 2015
Method for treating sarcopenia using antagonist antibodies against GDF-8 Grant US-8956608-B2 United States of America 17 Feb 2015